| Bioactivity | Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesis by binding to 23S ribosomal RNA (rRNA) of the 50S subunit of the ribosome. | ||||||||||||
| Invitro | Tedizolid (0.25 μg/mL) inhibits all 28 clinical isolates of PRSP, and is 4-fold more potent than linezolid against PRSP[1]. | ||||||||||||
| Name | Tedizolid | ||||||||||||
| CAS | 856866-72-3 | ||||||||||||
| Formula | C17H15FN6O3 | ||||||||||||
| Molar Mass | 370.34 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Tedizolid
CAS: 856866-72-3 F: C17H15FN6O3 W: 370.34
Tedizolid (TR 700; Torezolid; DA-7157) is a novel oxazolidinone, acting through inhibition of bacterial protein synthesi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.